Join Jerald P. Radich, MD and Cecilia Yeung, MD from Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance as they present their expertise on a range of cases pertaining to chronic myeloid leukemia (CML).
Join Jerald P. Radich, MD and Cecilia Yeung, MD from Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance as they present their expertise on a range of cases pertaining to chronic myeloid leukemia (CML).
The 2016 NCCN Case Manager and Medical Director Program Live Webinar Series will consist of six webinars on the topics of colorectal cancer, prostate cancer, distress management, CML, ovarian cancer, and multiple myeloma.
The NCCN Guidelines for Chronic Myeloid Leukemia (CML) provide recommendations for the management of chronic-phase and advanced-phase CML in adult patients. The median age of disease onset is 67 years.
The 2016 NCCN Case Manager and Medical Director Program Live Webinar Series will consist of six webinars on the topics of colorectal cancer, prostate cancer, distress management, CML, ovarian cancer, and multiple myeloma.
This information was originally presented at the NCCN 21st Annual Conference: Advancing the Standard of Cancer Care™ held in Hollywood, Florida, from March 31 – April 2, 2016.
NCCN Evidence Blocks™ are intended as a visual representation of five key measures that provide important information about specific recommendations contained within the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®).
This webcast with patient-physician video case studies will review the safety and efficacy profile of TKIs, the importance of molecular monitoring, and the significance of response milestones in the treatment of chronic myelogenous leukemia (CML).
Facebook
X
LinkedIn
Forward
